CDAI (Crohn's Disease)

Crohn's Disease Activity Index assessment.

Medical Disclaimer

This tool is for educational and screening purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Cirrhosis Prognosis

Bilirubin (mg/dL)

INR

Creatinine (mg/dL)

Sodium (mEq/L)

MELD-Na Score

Used for liver transplant prioritization.

Higher scores correlate with increased 3-month mortality risk.

Found this tool helpful? Share it with your friends!

About CDAI (Crohn's Disease)

The Crohn's Disease Activity Index (CDAI) is a widely recognized quantitative tool used to assess the severity and activity of Crohn's disease. Designed primarily for clinicians and researchers, it provides a standardized method for evaluating a patient's disease state over a 7-day period. The CDAI integrates eight weighted variables, including patient-reported symptoms like abdominal pain and stool frequency, general well-being, and clinical observations such as the use of antidiarrheal drugs, presence of extraintestinal manifestations, and hematocrit levels. This comprehensive approach yields a numerical score, with higher scores indicating increased disease activity. Its value lies in enabling objective monitoring of disease progression, guiding treatment decisions, and serving as a critical endpoint in clinical trials for new therapies.

Medical Disclaimer

Cirrhosis Prognosis

Bilirubin (mg/dL)

INR

Creatinine (mg/dL)

Sodium (mEq/L)